1,124
Views
2
CrossRef citations to date
0
Altmetric
REVIEW

Use of Vaping as a Smoking Cessation Aid: A Review of Clinical Trials

ORCID Icon
Pages 2137-2144 | Received 04 May 2023, Accepted 21 Jul 2023, Published online: 27 Jul 2023

References

  • Chiba M, Masironi R. Toxic and trace elements in tobacco and tobacco smoke. Bull World Health Organ. 1992;70(2):269–275.
  • United States Department of Health Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: United States Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
  • Chang JT, Anic GM, Rostron BL, et al. Cigarette smoking reduction and health risks: a systematic review and meta-analysis. Nicotine Tob Res. 2021;23(4):635–642. doi:10.1093/ntr/ntaa156
  • Jha P. The hazards of smoking and the benefits of cessation: a critical summation of the epidemiological evidence in high-income countries. eLife. 2020;9:e49979. doi:10.7554/eLife.49979
  • Reitsma MB, Fullman N, Ng M; GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017;389(10082):1885–1906. doi:10.1016/S0140-6736(17)30819-X
  • Husain MJ, Datta BK, Nargis N, et al. Revisiting the association between worldwide implementation of the MPOWER package and smoking prevalence, 2008–2017. Tob Control. 2021;30(6):630–637. doi:10.1136/tobaccocontrol-2020-055758
  • World Health Organization. WHO Global Report on Trends in Prevalence of Tobacco Use 2000–2025. World Health Organization; 2019.
  • Hoffmann D, Hoffmann I, El-Bayoumy K. The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder. Chem Res Toxicol. 2001;14(7):767–790. doi:10.1021/tx000260u
  • Akiyama Y, Sherwood N. Systematic review of biomarker findings from clinical studies of electronic cigarettes and heated tobacco products. Toxicol Rep. 2021;8:282–294. doi:10.1016/j.toxrep.2021.01.014
  • Pirie K, Peto R, Reeves GK, et al. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet. 2013;381(9861):133–141. doi:10.1016/S0140-6736(12)61720-6
  • Doll R, Peto R, Wheatley K, et al. Mortality in relation to smoking: 40 years’ observations on male British doctors. BMJ. 1994;309(6959):901–911. doi:10.1136/bmj.309.6959.901
  • Huerta TR, Walker DM, Mullen D, et al. Trends in e-cigarette awareness and perceived harmfulness in the US. Am J Prev Med. 2017;52(3):339–346. doi:10.1016/j.amepre.2016.10.017
  • Rigotti N, Kalkhoran S. Vaping and e-Cigarettes. Waltham (MA): UpToDate; 2021.
  • Levy DT, Warner KE, Cummings KM, et al. Examining the relationship of vaping to smoking initiation among US youth and young adults: a reality check. Tob Control. 2019;28(6):629–635. doi:10.1136/tobaccocontrol-2018-054446
  • Boakye E, Obisesan OH, Osei AD, et al. The promise and peril of vaping. Curr Cardiol Rep. 2020;22(12):155. doi:10.1007/s11886-020-01414-x
  • Fernández E, Ballbè M, Sureda X, et al. Particulate matter from electronic cigarettes and conventional cigarettes: a systematic review and observational study. Curr Environ Health Rep. 2015;2(4):423–429. doi:10.1007/s40572-015-0072-x
  • Farsalinos KE, Yannovits N, Sarri T, et al. Carbonyl emissions from a novel heated tobacco product (IQOS): comparison with an e-cigarette and a tobacco cigarette. Addiction. 2018;113(11):2099–2106. doi:10.1111/add.14365
  • Kaisar MA, Prasad S, Liles T, et al. A decade of e-cigarettes: limited research and unresolved safety concerns. Toxicology. 2016;365:67–75. doi:10.1016/j.tox.2016.07.020
  • Chaloupka FJ, Yurekli A, Fong GT. Tobacco taxes as a tobacco control strategy. Tob Control. 2012;21(2):172–180. doi:10.1136/tobaccocontrol-2011-050417
  • International Agency for Research on Cancer. Evaluating the Effectiveness of Smoke-Free Policies. IARC Press, International Agency for Research on Cancer; 2009.
  • Hopkins DP, Razi S, Leeks KD, et al. Smokefree policies to reduce tobacco use. A systematic review. Am J Prev Med. 2010;38(2):S275–S289. doi:10.1016/j.amepre.2009.10.029
  • Goldberg DN, Krantz AJ, Semal S, et al. Outcomes for a public hospital tobacco cessation program: the Cook County health and hospitals system experience. J Community Health. 2016;41(6):1130–1139. doi:10.1007/s10900-016-0215-5
  • Çelik İ, Yüce D, Hayran M, et al. Nationwide smoking cessation treatment support program—Turkey project. Health Policy (New York). 2015;119(1):50–56. doi:10.1016/j.healthpol.2014.11.017
  • Burton SL, Gitchell JG, Shiffman S; Centers for Disease Control and Prevention (CDC). Use of FDA-approved pharmacologic treatments for tobacco dependence—United States, 1984–1998. MMWR Morb Mortal Wkly Rep. 2000;49(29):665–668.
  • Prochaska JJ, Benowitz NL. The past, present, and future of nicotine addiction therapy. Annu Rev Med. 2016;67:467–486. doi:10.1146/annurev-med-111314-033712
  • Hajek P, Phillips-Waller A, Przulj D, et al. A Randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med. 2019;380(7):629–637. doi:10.1056/NEJMoa1808779
  • Barbeau AM, Burda J, Siegel M. Perceived efficacy of e-cigarettes versus nicotine replacement therapy among successful e-cigarette users: a qualitative approach. Addict Sci Clin Pract. 2013;8(1):5. doi:10.1186/1940-0640-8-5
  • World Health Organization. Electronic Nicotine Delivery Systems and Electronic Non-nicotine Delivery Systems (ENDS/ENNDS); 2016. Available from: www.who.int/fctc/cop/cop7/FCTC_COP_7_11_EN.pdf. Accessed January 27, 2018.
  • Zhu SH, Zhuang YL, Wong S, et al. E-cigarette use and associated changes in population smoking cessation: evidence from US current population surveys. BMJ. 2017;358:j3262. doi:10.1136/bmj.j3262
  • Meltzer LR, Simmons VN, Piñeiro B, et al. Development of a self-help smoking cessation intervention for dual users of tobacco cigarettes and e-cigarettes. Int J Environ Res Public Health. 2021;18(5):2328. doi:10.3390/ijerph18052328
  • Polosa P. Smoking cessation and reduction with an electronic nicotine delivery device (ENDD). NLM identifier: NCT01195597. Available from: https://classic.clinicaltrials.gov/ct2/show/NCT01195597. Accessed January 09, 2013.
  • Foundation for a Smoke Free World INC. Zonisamide/bupropion effects on switching to electronic cigarettes (BuZonE). NLM identifier: NCT04388319. Available from: https://classic.clinicaltrials.gov/ct2/show/NCT04388319. Accessed April 13, 2022.
  • Vickerman K. Enhanced E-cigarette coaching intervention for dual users of cigarettes and e-cigarettes. NLM identifier: NCT03575468. Available from: https://classic.clinicaltrials.gov/ct2/show/NCT03575468. Accessed September 10, 2022.
  • Foundation for a Smoke Free World INC. Combination of e-cigarettes and varenicline for tobacco harm reduction (EVAR). NLM identifier: NCT04210180. Available from: https://classic.clinicaltrials.gov/ct2/show/NCT04210180. Accessed February 24, 2022.
  • Lee SM. The END perioperative smoking pilot study. NLM identifier: NCT02482233. Available from: https://classic.clinicaltrials.gov/ct2/show/NCT02482233. Accessed March 09, 2022.
  • Fallin-Bennett A, Lofwall M, Waters T, et al. Behavioral and enhanced perinatal intervention (B-EPIC): a randomized trial targeting tobacco use among opioid dependent pregnant women. Contemp Clin Trials Commun. 2020;20:100657. doi:10.1016/j.conctc.2020.100657
  • Rostron BL, Chang CM, Pechacek TF. Estimation of cigarette smoking-attributable morbidity in the United States. JAMA Intern Med. 2014;174(12):1922–1928. doi:10.1001/jamainternmed.2014.5219
  • Burns DM, Dybing E, Gray N, et al. Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal. Tob Control. 2008;17(2):132–141. doi:10.1136/tc.2007.024158
  • Pappas RS. Toxic elements in tobacco and in cigarette smoke: inflammation and sensitization. Metallomics. 2011;3(11):1181–1198. doi:10.1039/c1mt00066g
  • Food and Drug Administration. Harmful and potentially harmful constituents in tobacco products and tobacco smoke: established list; 2012. Available from: https://www.fda.gov/TobaccoProducts/GuidanceComplianceRegulatoryInformation/ucm297786.htm. Accessed January 27, 2018.
  • Mutti A, Corradi M, Goldoni M, et al. Exhaled metallic elements and serum pneumoproteins in asymptomatic smokers and patients with COPD or asthma. Chest. 2006;129(5):1288–1297. doi:10.1378/chest.129.5.1288
  • Snider GL, Hayes JA, Korthy AL, et al. Centrilobular emphysema experimentally induced by cadmium chloride aerosol. Am Rev Respir Dis. 1973;108(1):40–48. doi:10.1164/arrd.1973.108.1.40
  • Snider GL, Lucey EC, Faris B, et al. Cadmium-chloride-induced air-space enlargement with interstitial pulmonary fibrosis is not associated with destruction of lung elastin. Implications for the pathogenesis of human emphysema. Am Rev Respir Dis. 1988;137(4):918–923. doi:10.1164/ajrccm/137.4.918
  • Lee MY, Jung BI, Chung SM, et al. Arsenic-induced dysfunction in relaxation of blood vessels. Environ Health Perspect. 2003;111(4):513–517. doi:10.1289/ehp.5916
  • Caponnetto P, Russo C, Polosa R. Smoking cessation: present status and future perspectives. Curr Opin Pharmacol. 2012;12(3):229–237. doi:10.1016/j.coph.2012.02.005
  • García-Gómez L, Hernández-Pérez A, Noé-Díaz V, et al. Smoking cessation treatments: current psychological and pharmacological options. Rev Invest Clin. 2019;71(1):7–16. doi:10.24875/RIC.18002629
  • Sanchez S, Kaufman P, Pelletier H, et al. Is vaping cessation like smoking cessation? A qualitative study exploring the responses of youth and young adults who vape e-cigarettes. Addict Behav. 2021;113:106687. doi:10.1016/j.addbeh.2020.106687
  • Ford A, MacKintosh AM, Bauld L, et al. Adolescents’ responses to the promotion and flavouring of e-cigarettes. Int J Public Health. 2016;61(2):215–224. doi:10.1007/s00038-015-0769-5
  • Perry RN, Girgulis JP, Harrison SL, et al. Dual users’ perceptions of the addictive properties of cigarettes versus E-cigarettes. Addict Behav. 2023;136:107483. doi:10.1016/j.addbeh.2022.107483
  • Kuschner WG, Reddy S, Mehrotra N, et al. Electronic cigarettes and thirdhand tobacco smoke: two emerging health care challenges for the primary care provider. Int J Gen Med. 2011;4:115–120. doi:10.2147/IJGM.S16908
  • Brown J, Beard E, Kotz D, et al. Real‐world effectiveness of e‐cigarettes when used to aid smoking cessation: a cross‐sectional population study. Addiction. 2014;109(9):1531–1540. doi:10.1111/add.12623
  • Chen R, Pierce JP, Leas EC, et al. Effectiveness of e-cigarettes as aids for smoking cessation: evidence from the PATH Study cohort, 2017–2019. Tob Control. 2022. doi:10.1136/tobaccocontrol-2021-056901
  • McDermott MS, East KA, Brose LS, et al. The effectiveness of using e‐cigarettes for quitting smoking compared to other cessation methods among adults in the United Kingdom. Addiction. 2021;116(10):2825–2836. doi:10.1111/add.15474
  • Hajek P, Phillips-Waller A, Przulj D, et al. E-cigarettes compared with nicotine replacement therapy within the UK Stop Smoking Services: the TEC RCT. Health Technol Assess. 2019;23(43):1–82. doi:10.3310/hta23430
  • Kasza KA, Hammond D, Gravely S, et al. Associations between nicotine vaping uptake and cigarette smoking cessation vary by smokers’ plans to quit: longitudinal findings from the International Tobacco Control Four Country Smoking and Vaping Surveys. Addiction. 2023;118(2):340–352. doi:10.1111/add.16050
  • Saffer H, Dench D, Grossman M, et al. E-cigarettes and adult smoking: evidence from Minnesota. J Risk Uncertain. 2020;60(3):207–228. doi:10.1007/s11166-020-09326-5
  • Esteban-Lopez M, Perry MD, Garbinski LD, et al. Health effects and known pathology associated with the use of E-cigarettes. Toxicol Rep. 2022;9:1357–1368. doi:10.1016/j.toxrep.2022.06.006
  • Chapman S, Bareham D, Maziak W. The gateway effect of E-cigarettes: reflections on main criticisms. Nicotine Tob Res. 2019;21(5):695–698. doi:10.1093/ntr/nty067
  • O’Farrell HE, Brown R, Brown Z, et al. E-cigarettes induce toxicity comparable to tobacco cigarettes in airway epithelium from patients with COPD. Toxicol in vitro. 2021;75:105204. doi:10.1016/j.tiv.2021.105204
  • Gee RE, Boles WR, Smith DG. E-cigarettes: a public health threat, not a population health intervention. Am J Public Health. 2021;111(2):224–226. doi:10.2105/AJPH.2020.306072